Dr. Kottilil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 W Lombard St
Baltimore, MD 21201Phone+1 410-328-9102Fax+1 410-706-4619
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2000 - 2002
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1997 - 2000
Government Medical College ThrissurClass of 1991
Certifications & Licensure
DC State Medical License 2009 - 2026
MD State Medical License 2014 - 2026
VA State Medical License 2001 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV Start of enrollment: 1993 Mar 09
- Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection Start of enrollment: 2010 Jul 01
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection Start of enrollment: 2011 Aug 23
- Join now to see all
Publications & Presentations
PubMed
- Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.Homie A Razavi, Imam Waked, Huma Qureshi, Loreta A Kondili, Ann-Sofi Duberg
Journal of Hepatology. 2025-02-04 - A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal Cytology.Omar Harfouch, Darren Whitfield, Tural Mammadli, Rahwa Eyasu, Connor Volpi
AIDS Patient Care and Stds. 2025-02-01 - 1 citationsLeveraging Old Hepatitis C Therapies.S Sean Tu, Shyamasundaran Kottilil, T Joseph Mattingly 2nd
The New England Journal of Medicine. 2024-12-28
Press Mentions
Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients with Unfavorable Treatment CharacteristicsA Randomized Clinical TrialSeptember 19th, 2019
UM School of Medicine Awarded Nearly $30 Million to Improve Health Outcomes of IV Drug UsersDecember 13th, 2023- UM School of Medicine Awarded Nearly $30 Million to Prevent Infections Associated with IV Drug UseDecember 21st, 2023
Grant Support
- Novel therapy for alcoholic liver disease-associated hepatorenal syndromeMITOPOWER LLC2021–2026
- Therapeutic Strategies For The Management Of HCV/HIV CO-National Institute Of Allergy And Infectious Diseases2006
- Role Of Innate Immunity In The Initiation And PathogenesNational Institute Of Allergy And Infectious Diseases2006
Professional Memberships
- Master
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
